SCHEMBL21751359

SCHEMBL21751359

O=c1c(Cc2ccc(F)cc2)nc2c(Cc3ccccc3)[nH]c(-c3cccc(O)c3)cn1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ CASR P41180 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ PARP1 P09874 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ ARF6 P62330 1/20 0.33
▸ KIF11 P52732 3/20 0.33
▸ EGFR P00533 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CDC7 O00311 1/20 0.32
▸ CYP17A1 P05093 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751336 0.94 ADORA3 (0.41) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL21751454 0.93 ADORA3 (0.39) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL30800148 0.93 ADORA3 (0.39) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL25760174 0.91 CASR (0.38) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL16154083 0.90 ADORA3 (0.38) ADORA3HTTALDH1A1MEN1KMT2A
SCHEMBL21751457 0.89 L3MBTL1 (0.34) ADORA3ADORA2AADORA1HTTALDH1A1
SCHEMBL13401854 0.89 ABCB1 (0.39) ADORA3ADORA1HTTALDH1A1PARP1
SCHEMBL19206714 0.89 ALDH1A1 (0.38) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL25760289 0.89 KMT2A (0.36) ALDH1A1MEN1KMT2A
SCHEMBL25760164 0.89 ADORA3 (0.37) ADORA3ADORA2AADORA1CASRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3981839-B1 COELENTERAZINE ANALOGS FOR USE IN LUCIFERASE-BASED ASSAYS PROMEGA CORP (US) 2025-08-20 — — EP disclosed
US-20240059697-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2024-02-22 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
EP-3841173-A1 COELENTERAZINE ANALOGUES Promega Corporation (US) 2021-06-30 — — EP disclosed
WO-2020041579-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION (US) 2020-02-27 — — WO disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062766-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ADORA3 3089/4885ADORA2A 1970/4885ADORA1 4310/4885
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 ADORA3 3089/4885ADORA2A 1970/4885ADORA1 4310/4885
US-20240059697-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ADORA3 3089/4885ADORA2A 1970/4885ADORA1 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback